Buscar
Cryoport Inc
CYRXAñadir a la lista de seguimiento
15.080USD
-0.250-1.63%
Cierre 07-31 16:00（ET）Cotizaciones retrasadas 15 min
755.04MCap. mercado
10.53P/E TTM
Más Datos de Cryoport Inc Compañía
Cryoport, Inc. provides temperature-controlled supply chain solutions for the Life Sciences, with an emphasis on regenerative medicine. The Company supports biopharmaceutical companies, contract manufacturers (CDMOs), contract research organizations (CROs), developers, and researchers with a comprehensive suite of services and products. Its integrated supply chain platform includes the Cryoportal Logistics Management Platform, advanced temperature-controlled packaging, informatics, specialized biologistics, biostorage, bioservices, and cryogenic systems. The Company's segments include Life Sciences Services and Life Sciences Products. The Company's Life Sciences Services segment provides cryogenic biostorage within the life science industry through direct sales. Its Life Sciences Products segment manufactures and sells cryogenic freezers, cryogenic dewars and accessories within the life science industry through direct sales or a distribution network.
Información de Cryoport Inc
Símbolo de cotizaciónCYRX
Nombre de la empresaCryoport Inc
Fecha de salida a bolsaJul 24, 2015
Director ejecutivoShelton (Jerrell Wilson)
Número de empleados1090
Tipo de seguridadOrdinary Share
Fin del año fiscalJul 24
Dirección112 Westwood Place, Suite 350
CiudadBRENTWOOD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal37027
Teléfono19492321900
Sitio Webhttps://www.cryoport.com/
Símbolo de cotizaciónCYRX
Fecha de salida a bolsaJul 24, 2015
Director ejecutivoShelton (Jerrell Wilson)
Ejecutivos de Cryoport Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.23M
+17.51%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
61.63K
+16.80%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
Dr. Ramkumar Mandalam, Ph.D.
Dr. Ramkumar Mandalam, Ph.D.
Independent Director
Independent Director
--
--
Mr. Ram M. Jagannath
Mr. Ram M. Jagannath
Independent Director
Independent Director
--
--
Mr. Mark Sawicki
Mr. Mark Sawicki
Senior Vice President, Chief Scientific Officer
Senior Vice President, Chief Scientific Officer
--
--
Mr. Scott Eckstein
Mr. Scott Eckstein
Investor Relations
Investor Relations
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Jerrell Wilson (Jerry) Shelton
Mr. Jerrell Wilson (Jerry) Shelton
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.23M
+17.51%
Mr. Daniel M. (Dan) Hancock
Mr. Daniel M. (Dan) Hancock
Independent Director
Independent Director
69.05K
+14.99%
Ms. Linda Baddour
Ms. Linda Baddour
Independent Director
Independent Director
68.10K
+15.20%
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Dr. Robert J. (Bob) Hariri, M.D., Ph.D.
Independent Director
Independent Director
61.63K
+16.80%
Mr. Robert S. Stefanovich
Mr. Robert S. Stefanovich
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
Chief Financial Officer, Senior Vice President, Chief Administrative Officer
--
--
Mr. Edward J. Zecchini
Mr. Edward J. Zecchini
Senior Vice President, Chief Digital and Technology Officer
Senior Vice President, Chief Digital and Technology Officer
--
--
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Cryoport Inc?
Los cinco principales accionistas de Cryoport Inc son: Mr. Jerrell Wilson (Jerry) Shelton
¿Cuántas instituciones poseen acciones de Cryoport Inc (CYRX)?
A fecha de 2026Q1, 382 instituciones poseen acciones de Cryoport Inc, con un valor de mercado combinado de aproximadamente 49.22M, lo que representa el 97.68% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -11194831.00.
¿Cuál es la mayor fuente de ganancias de Cryoport Inc?
El 2026Q1, el segmento empresarial Life Science products generó la ganancia más alta para Cryoport Inc, ascendiendo a 79.68M y representando el 45.23% de la ganancia total.